As Passed by the House

127th General Assembly Regular Session 2007-2008

Am. H. B. No. 215

Representative Collier 

Cosponsors: Representatives Evans, Latta, Brown, Chandler, Stebelton, Combs, Setzer, Aslanides, Bacon, Batchelder, Blessing, Book, Boyd, Core, Daniels, DeBose, DeGeeter, Dodd, Domenick, Dyer, Flowers, Gibbs, Hagan, J., Hagan, R., Mallory, Patton, Schindel, Schlichter, Sears, Wagner, Williams, B., Williams, S., Yuko 

---

A BILL

To amend section 3719.41 of the Revised Code to list

1

Salvia divinorum as a controlled substance.

2

BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF OHIO:

Section 1. That section 3719.41 of the Revised Code be	3
amended to read as follows:	4

Sec. 3719.41.  Controlled substance schedules I, II, III, IV,	5
and V are hereby established, which schedules include the	6
following, subject to amendment pursuant to section 3719.43 or	7
3719.44 of the Revised Code.	8

SCHEDULE I	9

(A) Narcotics-opiates

10

Any of the following opiates, including their isomers,	11
esters, ethers, salts, and salts of isomers, esters, and ethers,	12
unless specifically excepted under federal drug abuse control	13
laws, whenever the existence of these isomers, esters, ethers, and	14
salts is possible within the specific chemical designation:	15

(1) Acetyl-alpha-methylfentanyl	16
(N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);	17

(2) Acetylmethadol;

18

(3) Allylprodine;

19

(4) Alphacetylmethadol (except levo-alphacetylmethadol, also	20
known as levo-alpha-acetylmethadol, levomethadyl acetate, or	21
LAAM);	22

(5) Alphameprodine;

23

(6) Alphamethadol;

24

(7) Alpha-methylfentanyl	25
(N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl] propionanilide;	26
1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine);	27

(8) Alpha-methylthiofentanyl	28
(N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-	29
phenylpropanamide);	30

(9) Benzethidine;

31

(10) Betacetylmethadol;

32

(11) Beta-hydroxyfentanyl	33
(N-[1-(2-hydroxy-2-phenethyl-4-piperidinyl]-N- phenylpropanamide);	34

(12) Beta-hydroxy-3-methylfentanyl (other name:	35
N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-	36
phenylpropanamide);	37

(13) Betameprodine;

38

(14) Betamethadol;

39

(15) Betaprodine;

40

(16) Clonitazene;

41

(17) Dextromoramide;

42

(18) Diampromide;

43

(19) Diethylthiambutene;

44

(20) Difenoxin;

45

(21) Dimenoxadol;

46

(22) Dimepheptanol;

47

(23) Dimethylthiambutene;

48

(24) Dioxaphetyl butyrate;

49

(25) Dipipanone;

50

(26) Ethylmethylthiambutene;

51

(27) Etonitazene;

52

(28) Etoxeridine;

53

(29) Furethidine;

54

(30) Hydroxypethidine;

55

(31) Ketobemidone;

56

(32) Levomoramide;

57

(33) Levophenacylmorphan;

58

(34) 3-methylfentanyl	59
(N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-	60
phenylpropanamide):;	61

(35) 3-methylthiofentanyl	62
(N-[3-methyl-1-[2-(thienyl)ethyl]-4-piperidinyl]-N-	63
phenylpropanamide);	64

(36) Morpheridine;

65

(37) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);

66

(38) Noracymethadol;

67

(39) Norlevorphanol;

68

(40) Normethadone;

69

(41) Norpipanone;

70

(42) Para-fluorofentanyl	71
(N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl]propanamide;	72

(43) PEPAP (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine;

73

(44) Phenadoxone;

74

(45) Phenampromide;

75

(46) Phenomorphan;

76

(47) Phenoperidine;

77

(48) Piritramide;

78

(49) Proheptazine;

79

(50) Properidine;

80

(51) Propiram;

81

(52) Racemoramide;

82

(53) Thiofentanyl	83
(N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide;	84

(54) Tilidine;

85

(55) Trimeperidine.

86

(B) Narcotics-opium derivatives

87

Any of the following opium derivatives, including their	88
salts, isomers, and salts of isomers, unless specifically excepted	89
under federal drug abuse control laws, whenever the existence of	90
these salts, isomers, and salts of isomers is possible within the	91
specific chemical designation:	92

(1) Acetorphine;

93

(2) Acetyldihydrocodeine;

94

(3) Benzylmorphine;

95

(4) Codeine methylbromide;

96

(5) Codeine-n-oxide;

97

(6) Cyprenorphine;

98

(7) Desomorphine;

99

(8) Dihydromorphine;

100

(9) Drotebanol;

101

(10) Etorphine (except hydrochloride salt);

102

(11) Heroin;

103

(12) Hydromorphinol;

104

(13) Methyldesorphine;

105

(14) Methyldihydromorphine;

106

(15) Morphine methylbromide;

107

(16) Morphine methylsulfonate;

108

(17) Morphine-n-oxide;

109

(18) Myrophine;

110

(19) Nicocodeine;

111

(20) Nicomorphine;

112

(21) Normorphine;

113

(22) Pholcodine;

114

(23) Thebacon.

115

(C) Hallucinogens

116

Any material, compound, mixture, or preparation that contains	117
any quantity of the following hallucinogenic substances, including	118
their salts, isomers, and salts of isomers, unless specifically	119
excepted under federal drug abuse control laws, whenever the	120
existence of these salts, isomers, and salts of isomers is	121
possible within the specific chemical designation. For the	122
purposes of this division only, "isomer" includes the optical	123
isomers, position isomers, and geometric isomers.	124

(1) Alpha-ethyltryptamine (some trade or other names:	125
etryptamine; Monase; alpha-ethyl-1H-indole-3-ethanamine;	126
3-(2-aminobutyl) indole; alpha-ET; and AET);	127

(2) 4-bromo-2,5-dimethoxyamphetamine (some trade or other	128
names: 4-bromo-2,5-dimethoxy-alpha-methyphenethylamine;	129
4-bromo-2,5-DMA);	130

(3) 4-bromo-2,5-dimethoxyphenethylamine (some trade or other	131
names: 2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane;	132
alpha-desmethyl DOB; 2C-B, Nexus);	133

(4) 2,5-dimethoxyamphetamine (some trade or other names:	134
2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA);	135

(5) 2,5-dimethoxy-4-ethylamphetamine (some trade or other	136
names: DOET);	137

(6) 4-methoxyamphetamine (some trade or other names:	138
4-methoxy-alpha-methylphenethylamine; paramethoxyamphetamine;	139
PMA);	140

(7) 5-methoxy-3,4-methylenedioxy-amphetamine;

141

(8) 4-methyl-2,5-dimethoxy-amphetamine (some trade or other	142
names: 4-methyl-2,5-dimethoxy-alpha-methylphenethylamine; "DOM"	143
and "STP");	144

(9) 3,4-methylenedioxy amphetamine;

145

(10) 3,4-methylenedioxymethamphetamine (MDMA);

146

(11) 3,4-methylenedioxy-N-ethylamphetamine (also known as	147
N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl	148
MDA, MDE, MDEA);	149

(12) N-hydroxy-3,4-methylenedioxyamphetamine (also known as	150
N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine and	151
N-hydroxy MDA);	152

(13) 3,4,5-trimethoxy amphetamine;

153

(14) Bufotenine (some trade or other names:	154
3-(beta-dimethylaminoethyl)-5-hydroxyindole:;	155
3-(2-dimethylaminoethyl)-5-indolol:; N, N-dimethylserotonin;	156
5-hydroxy-N, N-dimethyltryptamine; mappine);	157

(15) Diethyltryptamine (some trade or other names: N,	158
N-diethyltryptamine; DET);	159

(16) Dimethyltryptamine (some trade or other names: DMT);

160

(17) Ibogaine (some trade or other names:	161
7-ethyl-6,6beta,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-	162
5H-pyrido[1',2':1,2] azepino [5, 4-b] indole; tabernanthe iboga);	163

(18) Lysergic acid diethylamide;

164

(19) Marihuana;

165

(20) Mescaline;

166

(21) Parahexyl (some trade or other names: 3-hexyl-1-	167
hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran;	168
synhexyl);	169

(22) Peyote (meaning all parts of the plant presently	170
classified botanically as "Lophophora williamsii Lemaire," whether	171
growing or not, the seeds of that plant, any extract from any part	172
of that plant, and every compound, manufacture, salts, derivative,	173
mixture, or preparation of that plant, its seeds, or its	174
extracts);	175

(23) N-ethyl-3-piperidyl benzilate;

176

(24) N-methyl-3-piperidyl benzilate;

177

(25) Psilocybin;

178

(26) Psilocyn;

179

(27) Tetrahydrocannabinols (synthetic equivalents of the	180
substances contained in the plant, or in the resinous extractives	181
of Cannabis, sp. and/or synthetic substances, derivatives, and	182
their isomers with similar chemical structure and pharmacological	183
activity such as the following: delta-1-cis or trans	184
tetrahydrocannabinol, and their optical isomers; delta-6-cis or	185
trans tetrahydrocannabinol, and their optical isomers;	186
delta-3,4-cis or trans tetrahydrocannabinol, and its optical	187
isomers. (Since nomenclature of these substances is not	188
internationally standardized, compounds of these structures,	189
regardless of numerical designation of atomic positions, are	190
covered.));	191

(28) Ethylamine analog of phencyclidine (some trade or other	192
names: N-ethyl-1-phenylcyclohexylamine; (1-phenyl-cyclohexyl	193
phenylcyclohexyl)ethylamine; N-(1-phenylcyclohexyl)ethylamine;	194
cyclohexamine; PCE);	195

(29) Pyrrolidine analog of phencyclidine (some trade or other	196
names: 1-(1-phenylcyclohexyl)pyrrolidine; PCPy; PHP);	197

(30) Thiophene analog of phencyclidine (some trade or other	198
names: 1-t[1-(2-thienyl)-cyclohexylu]-piperidine; 2-thienyl	199
analog of phencyclidine; TPCP; TCP);	200

(31) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine;

201

(32) Hashish;

202

(33) Salvia divinorum;

203

(34) Salvinorin A.

204

(D) Depressants

205

Any material, compound, mixture, or preparation that contains	206
any quantity of the following substances having a depressant	207
effect on the central nervous system, including their salts,	208
isomers, and salts of isomers, unless specifically excepted under	209
federal drug abuse control laws, whenever the existence of these	210
salts, isomers, and salts of isomers is possible within the	211
specific chemical designation:	212

(1) Mecloqualone;

213

(2) Methaqualone.

214

(E) Stimulants

215

Unless specifically excepted or unless listed in another	216
schedule, any material, compound, mixture, or preparation that	217
contains any quantity of the following substances having a	218
stimulant effect on the central nervous system, including their	219
salts, isomers, and salts of isomers:	220

(1) Aminorex (some other names: aminoxaphen;	221
2-amino-5-phenyl-2-oxazoline; or	222
4,5-dihydro-5-phenyl-2-oxazolamine);	223

(2) Cathinone (some trade or other names:	224
2-amino-1-phenyl-1-propanone, alpha-aminopropiophenone,	225
2-aminopropiophenone, and norephedrone);	226

(3) Fenethylline;

227

(4) Methcathinone (some other names:	228
2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone;	229
2-methylamino)-1-phenylpropan-1-one;	230
alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone;	231
N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and	232
UR1432), its salts, optical isomers, and salts of optical isomers;	233

(5) (+/-)cis-4-methylaminorex	234
((+/-)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);	235

(6) N-ethylamphetamine;

236

(7) N,N-dimethylamphetamine (also known as	237
N,N-alpha-trimethyl-benzeneethanamine;	238
N,N-alpha-trimethylphenethylamine).	239

SCHEDULE II	240

(A) Narcotics-opium and opium derivatives

241

Unless specifically excepted under federal drug abuse control	242
laws or unless listed in another schedule, any of the following	243
substances whether produced directly or indirectly by extraction	244
from substances of vegetable origin, independently by means of	245
chemical synthesis, or by a combination of extraction and chemical	246
synthesis:	247

(1) Opium and opiate, and any salt, compound, derivative, or	248
preparation of opium or opiate, excluding apomorphine,	249
thebaine-derived butorphanol, dextrorphan, nalbuphine, nalmefene,	250
naloxone, and naltrexone, and their respective salts, but	251
including the following:	252

(a) Raw opium;

253

(b) Opium extracts;

254

(c) Opium fluid extracts;

255

(d) Powdered opium;

256

(e) Granulated opium;

257

(f) Tincture of opium;

258

(g) Codeine;

259

(h) Ethylmorphine;

260

(i) Etorphine hydrochloride;

261

(j) Hydrocodone;

262

(k) Hydromorphone;

263

(l) Metopon;

264

(m) Morphine;

265

(n) Oxycodone;

266

(o) Oxymorphone;

267

(p) Thebaine.

268

(2) Any salt, compound, derivative, or preparation thereof	269
that is chemically equivalent to or identical with any of the	270
substances referred to in division (A)(1) of this schedule, except	271
that these substances shall not include the isoquinoline alkaloids	272
of opium;	273

(3) Opium poppy and poppy straw;

274

(4) Coca leaves and any salt, compound, derivative, or	275
preparation of coca leaves (including cocaine and ecgonine, their	276
salts, isomers, and derivatives, and salts of those isomers and	277
derivatives), and any salt, compound, derivative, or preparation	278
thereof that is chemically equivalent to or identical with any of	279
these substances, except that the substances shall not include	280
decocainized coca leaves or extraction of coca leaves, which	281
extractions do not contain cocaine or ecgonine;	282

(5) Concentrate of poppy straw (the crude extract of poppy	283
straw in either liquid, solid, or powder form that contains the	284
phenanthrene alkaloids of the opium poppy).	285

(B) Narcotics-opiates

286

Unless specifically excepted under federal drug abuse control	287
laws or unless listed in another schedule, any of the following	288
opiates, including their isomers, esters, ethers, salts, and salts	289
of isomers, esters, and ethers, whenever the existence of these	290
isomers, esters, ethers, and salts is possible within the specific	291
chemical designation, but excluding dextrorphan and	292
levopropoxyphene:	293

(1) Alfentanil;

294

(2) Alphaprodine;

295

(3) Anileridine;

296

(4) Bezitramide;

297

(5) Bulk dextropropoxyphene (non-dosage forms);

298

(6) Carfentanil;

299

(7) Dihydrocodeine;

300

(8) Diphenoxylate;

301

(9) Fentanyl;

302

(10) Isomethadone;

303

(11) Levo-alphacetylmethadol (some other names:	304
levo-alpha-acetylmethadol; levomethadyl acetate; LAAM);	305

(12) Levomethorphan;

306

(13) Levorphanol;

307

(14) Metazocine;

308

(15) Methadone;

309

(16) Methadone-intermediate,	310
4-cyano-2-dimethylamino-4,4-diphenyl butane;	311

(17) Moramide-intermediate,	312
2-methyl-3-morpholino-1,1-diphenylpropane-carboxylic acid;	313

(18) Pethidine (meperidine);

314

(19) Pethidine-intermediate-A,	315
4-cyano-1-methyl-4-phenylpiperidine;	316

(20) Pethidine-intermediate-B,	317
ethyl-4-phenylpiperidine-4-carboxylate;	318

(21) Pethidine-intermediate-C,	319
1-methyl-4-phenylpiperidine-4-carboxylic acid;	320

(22) Phenazocine;

321

(23) Piminodine;

322

(24) Racemethorphan;

323

(25) Racemorphan;

324

(26) Remifentanil;

325

(27) Sufentanil.

326

(C) Stimulants

327

Unless specifically excepted under federal drug abuse control	328
laws or unless listed in another schedule, any material, compound,	329
mixture, or preparation that contains any quantity of the	330
following substances having a stimulant effect on the central	331
nervous system:	332

(1) Amphetamine, its salts, its optical isomers, and salts of	333
its optical isomers;	334

(2) Methamphetamine, its salts, its isomers, and salts of its	335
isomers;	336

(3) Methylphenidate;

337

(4) Phenmetrazine and its salts.

338

(D) Depressants

339

Unless specifically excepted under federal drug abuse control	340
laws or unless listed in another schedule, any material, compound,	341
mixture, or preparation that contains any quantity of the	342
following substances having a depressant effect on the central	343
nervous system, including their salts, isomers, and salts of	344
isomers, whenever the existence of these salts, isomers, and salts	345
of isomers is possible within the specific chemical designation:	346

(1) Amobarbital;

347

(2) Gamma-hydroxy-butyrate;

348

(3) Glutethimide;

349

(4) Pentobarbital;

350

(5) Phencyclidine (some trade or other names:	351
1-(1-phenylcyclohexyl)piperidine; PCP);	352

(6) Secobarbital;

353

(7) 1-aminophenylcyclohexane and all N-mono-substituted	354
and/or all N-N-disubstituted analogs including, but not limited	355
to, the following:	356

(a) 1-phenylcyclohexylamine;

357

(b) (1-phenylcyclohexyl) methylamine;

358

(c) (1-phenylcyclohexyl) dimethylamine;

359

(d) (1-phenylcyclohexyl) methylethylamine;

360

(e) (1-phenylcyclohexyl) isopropylamine;

361

(f) 1-(1-phenylcyclohexyl) morpholine.

362

(E) Hallucinogenic substances

363

(1) Nabilone (another name for nabilone:	364
(+)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-	365
hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one).	366

(F) Immediate precursors

367

Unless specifically excepted under federal drug abuse control	368
laws or unless listed in another schedule, any material, compound,	369
mixture, or preparation that contains any quantity of the	370
following substances:	371

(1) Immediate precursor to amphetamine and methamphetamine:

372

(a) Phenylacetone (some trade or other names:	373
phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl	374
ketone);	375

(2) Immediate precursors to phencyclidine (PCP):

376

(a) 1-phenylcyclohexylamine;

377

(b) 1-piperidinocyclohexanecarbonitrile (PCC).

378

SCHEDULE III	379

(A) Stimulants

380

Unless specifically excepted under federal drug abuse control	381
laws or unless listed in another schedule, any material, compound,	382
mixture, or preparation that contains any quantity of the	383
following substances having a stimulant effect on the central	384
nervous system, including their salts, their optical isomers,	385
position isomers, or geometric isomers, and salts of these	386
isomers, whenever the existence of these salts, isomers, and salts	387
of isomers is possible within the specific chemical designation:	388

(1) All stimulant compounds, mixtures, and preparations	389
included in schedule III pursuant to the federal drug abuse	390
control laws and regulations adopted under those laws;	391

(2) Benzphetamine;

392

(3) Chlorphentermine;

393

(4) Clortermine;

394

(5) Phendimetrazine.

395

(B) Depressants

396

Unless specifically excepted under federal drug abuse control	397
laws or unless listed in another schedule, any material, compound,	398
mixture, or preparation that contains any quantity of the	399
following substances having a depressant effect on the central	400
nervous system:	401

(1) Any compound, mixture, or preparation containing	402
amobarbital, secobarbital, pentobarbital, or any salt of any of	403
these drugs, and one or more other active medicinal ingredients	404
that are not listed in any schedule;	405

(2) Any suppository dosage form containing amobarbital,	406
secobarbital, pentobarbital, or any salt of any of these drugs and	407
approved by the food and drug administration for marketing only as	408
a suppository;	409

(3) Any substance that contains any quantity of a derivative	410
of barbituric acid or any salt of a derivative of barbituric acid;	411

(4) Chlorhexadol;

412

(5) Ketamine, its salts, isomers, and salts of isomers (some	413
other names for ketamine:	414
(+/-)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone);	415

(6) Lysergic acid;

416

(7) Lysergic acid amide;

417

(8) Methyprylon;

418

(9) Sulfondiethylmethane;

419

(10) Sulfonethylmethane;

420

(11) Sulfonmethane;

421

(12) Tiletamine, zolazepam, or any salt of tiletamine or	422
zolazepam (some trade or other names for a tiletamine-zolazepam	423
combination product: Telazol); (some trade or other names for	424
tiletamine: 2-(ethylamino)-2-(2-thienyl)-cyclohexanone); (some	425
trade or other names for zolazepam: 4-(2-fluorophenyl)-6,8-	426
dihydro-1,3,8-trimethylpyrazolo-[3, 4-e][1,4]-diazepin-7(1H)-one;	427
flupyrazapon).	428

(C) Narcotic antidotes

429

(1) Nalorphine.

430

(D) Narcotics-narcotic preparations

431

Unless specifically excepted under federal drug abuse control	432
laws or unless listed in another schedule, any material, compound,	433
mixture, or preparation that contains any of the following	434
narcotic drugs, or their salts calculated as the free anhydrous	435
base or alkaloid, in limited quantities as set forth below:	436

(1) Not more than 1.8 grams of codeine per 100 milliliters or	437
not more than 90 milligrams per dosage unit, with an equal or	438
greater quantity of an isoquinoline alkaloid of opium;	439

(2) Not more than 1.8 grams of codeine per 100 milliliters or	440
not more than 90 milligrams per dosage unit, with one or more	441
active, nonnarcotic ingredients in recognized therapeutic amounts;	442

(3) Not more than 300 milligrams of dihydrocodeinone per 100	443
milliliters or not more than 15 milligrams per dosage unit, with a	444
fourfold or greater quantity of an isoquinoline alkaloid of opium;	445

(4) Not more than 300 milligrams of dihydrocodeinone per 100	446
milliliters or not more than 15 milligrams per dosage unit, with	447
one or more active, nonnarcotic ingredients in recognized	448
therapeutic amounts;	449

(5) Not more than 1.8 grams of dihydrocodeine per 100	450
milliliters or not more than 90 milligrams per dosage unit, with	451
one or more active, nonnarcotic ingredients in recognized	452
therapeutic amounts;	453

(6) Not more than 300 milligrams of ethylmorphine per 100	454
milliliters or not more than 15 milligrams per dosage unit, with	455
one or more active, nonnarcotic ingredients in recognized	456
therapeutic amounts;	457

(7) Not more than 500 milligrams of opium per 100 milliliters	458
or per 100 grams or not more than 25 milligrams per dosage unit,	459
with one or more active, nonnarcotic ingredients in recognized	460
therapeutic amounts;	461

(8) Not more than 50 milligrams of morphine per 100	462
milliliters or per 100 grams, with one or more active, nonnarcotic	463
ingredients in recognized therapeutic amounts.	464

(E) Anabolic steroids

465

Unless specifically excepted under federal drug abuse control	466
laws or unless listed in another schedule, any material, compound,	467
mixture, or preparation that contains any quantity of the	468
following substances, including their salts, esters, isomers, and	469
salts of esters and isomers, whenever the existence of these	470
salts, esters, and isomers is possible within the specific	471
chemical designation:	472

(1) Anabolic steroids. Except as otherwise provided in	473
division (E)(1) of schedule III, "anabolic steroids" means any	474
drug or hormonal substance that is chemically and	475
pharmacologically related to testosterone (other than estrogens,	476
progestins, and corticosteroids) and that promotes muscle growth.	477
"Anabolic steroids" does not include an anabolic steroid that is	478
expressly intended for administration through implants to cattle	479
or other nonhuman species and that has been approved by the United	480
States secretary of health and human services for that	481
administration, unless a person prescribes, dispenses, or	482
distributes this type of anabolic steroid for human use. "Anabolic	483
steroid" includes, but is not limited to, the following:	484

(a) Boldenone;

485

(b) Chlorotestosterone (4-chlortestosterone);

486

(c) Clostebol;

487

(d) Dehydrochlormethyltestosterone;

488

(e) Dihydrotestosterone (4-dihydrotestosterone);

489

(f) Drostanolone;

490

(g) Ethylestrenol;

491

(h) Fluoxymesterone;

492

(i) Formebulone (formebolone);

493

(j) Mesterolone;

494

(k) Methandienone;

495

(l) Methandranone;

496

(m) Methandriol;

497

(n) Methandrostenolone;

498

(o) Methenolone;

499

(p) Methyltestosterone;

500

(q) Mibolerone;

501

(r) Nandrolone;

502

(s) Norethandrolone;

503

(t) Oxandrolone;

504

(u) Oxymesterone;

505

(v) Oxymetholone;

506

(w) Stanolone;

507

(x) Stanozolol;

508

(y) Testolactone;

509

(z) Testosterone;

510

(aa) Trenbolone;

511

(bb) Any salt, ester, isomer, or salt of an ester or isomer	512
of a drug or hormonal substance described or listed in division	513
(E)(1) of schedule III if the salt, ester, or isomer promotes	514
muscle growth.	515

(F) Hallucinogenic substances

516

(1) Dronabinol (synthetic) in sesame oil and encapsulated in	517
a soft gelatin capsule in a United States food and drug	518
administration approved drug product (some other names for	519
dronabinol: (6aR-trans)-6a,7,8,10a-tetrahydro-	520
6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or	521
(-)-delta-9-(trans)-tetrahydrocannabinol).	522

SCHEDULE IV	523

(A) Narcotic drugs

524

Unless specifically excepted by federal drug abuse control	525
laws or unless listed in another schedule, any material, compound,	526
mixture, or preparation that contains any of the following	527
narcotic drugs, or their salts calculated as the free anhydrous	528
base or alkaloid, in limited quantities as set forth below:	529

(1) Not more than one milligram of difenoxin and not less	530
than 25 micrograms of atropine sulfate per dosage unit;	531

(2) Dextropropoxyphene	532
(alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-	533
propionoxybutane)t[final dosage formsu].	534

(B) Depressants

535

Unless specifically excepted under federal drug abuse control	536
laws or unless listed in another schedule, any material, compound,	537
mixture, or preparation that contains any quantity of the	538
following substances, including their salts, isomers, and salts of	539
isomers, whenever the existence of these salts, isomers, and salts	540
of isomers is possible within the specific chemical designation:	541

(1) Alprazolam;

542

(2) Barbital;

543

(3) Bromazepam;

544

(4) Camazepam;

545

(5) Chloral betaine;

546

(6) Chloral hydrate;

547

(7) Chlordiazepoxide;

548

(8) Clobazam;

549

(9) Clonazepam;

550

(10) Clorazepate;

551

(11) Clotiazepam;

552

(12) Cloxazolam;

553

(13) Delorazepam;

554

(14) Diazepam;

555

(15) Estazolam;

556

(16) Ethchlorvynol;

557

(17) Ethinamate;

558

(18) Ethyl loflazepate;

559

(19) Fludiazepam;

560

(20) Flunitrazepam;

561

(21) Flurazepam;

562

(22) Halazepam;

563

(23) Haloxazolam;

564

(24) Ketazolam;

565

(25) Loprazolam;

566

(26) Lorazepam;

567

(27) Lormetazepam;

568

(28) Mebutamate;

569

(29) Medazepam;

570

(30) Meprobamate;

571

(31) Methohexital;

572

(32) Methylphenobarbital (mephobarbital);

573

(33) Midazolam;

574

(34) Nimetazepam;

575

(35) Nitrazepam;

576

(36) Nordiazepam;

577

(37) Oxazepam;

578

(38) Oxazolam;

579

(39) Paraldehyde;

580

(40) Petrichloral;

581

(41) Phenobarbital;

582

(42) Pinazepam;

583

(43) Prazepam;

584

(44) Quazepam;

585

(45) Temazepam;

586

(46) Tetrazepam;

587

(47) Triazolam;

588

(48) Zaleplon;

589

(49) Zolpidem.

590

(C) Fenfluramine

591

Any material, compound, mixture, or preparation that contains	592
any quantity of the following substances, including their salts,	593
their optical isomers, position isomers, or geometric isomers, and	594
salts of these isomers, whenever the existence of these salts,	595
isomers, and salts of isomers is possible within the specific	596
chemical designation:	597

(1) Fenfluramine.

598

(D) Stimulants

599

Unless specifically excepted under federal drug abuse control	600
laws or unless listed in another schedule, any material, compound,	601
mixture, or preparation that contains any quantity of the	602
following substances having a stimulant effect on the central	603
nervous system, including their salts, their optical isomers,	604
position isomers, or geometric isomers, and salts of these	605
isomers, whenever the existence of these salts, isomers, and salts	606
of isomers is possible within the specific chemical designation:	607

(1) Cathine ((+)-norpseudoephedrine);

608

(2) Diethylpropion;

609

(3) Fencamfamin;

610

(4) Fenproporex;

611

(5) Mazindol;

612

(6) Mefenorex;

613

(7) Modafinil;

614

(8) Pemoline (including organometallic complexes and chelates	615
thereof);	616

(9) Phentermine;

617

(10) Pipradrol;

618

(11) Sibutramine;

619

(12) SPA [(-)-1-dimethylamino-1,2-diphenylethane].

620

(E) Other substances

621

Unless specifically excepted under federal drug abuse control	622
laws or unless listed in another schedule, any material, compound,	623
mixture, or preparation that contains any quantity of the	624
following substances, including their salts:	625

(1) Pentazocine;

626

(2) Butorphanol (including its optical isomers).

627

SCHEDULE V	628

(A) Narcotic drugs

629

Unless specifically excepted under federal drug abuse control	630
laws or unless listed in another schedule, any material, compound,	631
mixture, or preparation that contains any of the following	632
narcotic drugs, and their salts, as set forth below:	633

(1) Buprenorphine.

634

(B) Narcotics-narcotic preparations

635

Narcotic drugs containing non-narcotic active medicinal	636
ingredients. Any compound, mixture, or preparation that contains	637
any of the following narcotic drugs, or their salts calculated as	638
the free anhydrous base or alkaloid, in limited quantities as set	639
forth below, and that includes one or more nonnarcotic active	640
medicinal ingredients in sufficient proportion to confer upon the	641
compound, mixture, or preparation valuable medicinal qualities	642
other than those possessed by narcotic drugs alone:	643

(1) Not more than 200 milligrams of codeine per 100	644
milliliters or per 100 grams;	645

(2) Not more than 100 milligrams of dihydrocodeine per 100	646
milliliters or per 100 grams;	647

(3) Not more than 100 milligrams of ethylmorphine per 100	648
milliliters or per 100 grams;	649

(4) Not more than 2.5 milligrams of diphenoxylate and not	650
less than 25 micrograms of atropine sulfate per dosage unit;	651

(5) Not more than 100 milligrams of opium per 100 milliliters	652
or per 100 grams;	653

(6) Not more than 0.5 milligram of difenoxin and not less	654
than 25 micrograms of atropine sulfate per dosage unit.	655

(C) Stimulants

656

Unless specifically exempted or excluded under federal drug	657
abuse control laws or unless listed in another schedule, any	658
material, compound, mixture, or preparation that contains any	659
quantity of the following substances having a stimulant effect on	660
the central nervous system, including their salts, isomers, and	661
salts of isomers:	662

(1) Ephedrine, except as provided in division (K) of section	663
3719.44 of the Revised Code;	664

(2) Pyrovalerone.

665

Section 2. That existing section 3719.41 of the Revised Code	666
is hereby repealed.	667